An intact actin-containing cytoskeleton is required for capacitative calcium entry, but not for ATP-induced calcium-mediated cell signaling in cultured human keratinocytes

Medical Science Monitor

Volumn 9, Issue 6, 2003, Pages

  Korkiamäki, Timo ^a   Ylä Outinen, Heli ^a   Koivunen, Jussi ^a   Peltonen, Juha ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Intracellular calcium; Keratinocyte cultures; Neurofibromatosis; Neurofibromin; P2 purinergic receptors

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM CHANNEL; CYTOCHALASIN D; THAPSIGARGIN;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MEMBRANE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; HUMAN; HUMAN CELL; KERATINOCYTE; MICROFILAMENT; NEUROFIBROMATOSIS; SIGNAL TRANSDUCTION;

ACTINS; ADENOSINE TRIPHOSPHATE; ADULT; BIOLOGICAL TRANSPORT; CALCIUM; CELLS, CULTURED; CYTOCHALASIN D; CYTOSKELETON; HUMANS; KERATINOCYTES; MIDDLE AGED; NEUROFIBROMATOSIS 1; SIGNAL TRANSDUCTION; SKIN; THAPSIGARGIN;

EID: 0037830415     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Lodish H, Berk A, Zipursky SL et al: Molecular Cell Biology. (2nd printing). W.H. Freeman and Company, New York, 2000
2. Berridge MJ, Irvine RF: Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 1984; 312: 315-21
3. Pietrobon D, Di Virgilio F, Pozzan T: Structural and functional aspects of calcium homeostasis in eukaryotic cells. Eur J Biochem, 1990; 193: 599-622
4. Parekh AB, Penner R: Store depletion and calcium influx. Physiol Rev, 1997; 77: 901-930
5. Hu Z, Bonifas JM, Beech J et al: Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet, 2000; 24: 61-65
6. Sudbrak R, Brown J, Dobson-Stone C et al: Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet, 2000; 9: 1131-1140
7. Filvaroff E, Calautti E, Reiss M, Dotto GP: Functional evidence for an extracellular calcium receptor mechanism triggering tyrosine kinase activation associated with mouse keratinocyte differentiation. J Biol Chem, 1994; 269: 21735-21740
8. Bikle DD, Ratnam A, Mauro T et al: Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest, 1996; 97: 1085-1093
9. Tu CL, Oda Y, Bikle DD: Effects of a calcium receptor activator on the cellular response to calcium in human keratinocytes. J Invest Dermatol, 1999; 113: 340-345
10. Garrett JE, Capuano IV, Hammerland LG et al: Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem, 1995; 270: 12919-12925
11. Chattopadhyay N, Mithal A, Brown EM: The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev, 1996; 17: 289-307
12. Dutta D: Mechanism of store-operated calcium entry. J Biosci, 2000; 25: 397-404
13. Putney JW: A model for receptor-regulated calcium entry. Cell Calcium, 1986; 7: 1-12
14. Putney JW: Capacitative calcium entry revisited. Cell Calcium, 1990; 11: 611-624
15. Berridge MJ: Capacitative calcium entry. Biochem J, 1995; 312: 1-11
16. Putney JW Jr, Bird GS: The signal for capacitative calcium entry. Cell, 1993; 75: 199-201
17. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature, 1993; 361: 315-325
18. Clapham DE: Calcium signaling. Cell, 1995; 80: 259-268
19. Burnstock G: In: Cell Membrane Receptors for Drugs and Hormones. Straub RW and Bolis K, editors. Raven Press, Ltd, New York, 1978; 107-118
20. Cockcroft S, Grumperts BD: Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to rat mast cells. J Physiol, 1979; 296: 229-243
21. Cusack NJ, Hourani SMO, Welford LA: In: Mechanisms of Stimulus-Response Coupling in Platelets. Westwick J, MacInture DE, Scully NF, and Kakkar VV, editors. Plenum Publishing Corp, 1985; 128-146
22. Collins MG: In: Purines: Pharmacology and Physiological Roles, Stone TW, editor. Macmillan Publishers Ltd, London, 1985; 75-84
23. Osipchuk Y, Cahalan M: Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature, 1992; 359: 241-244
24. Dubyak GR, Cowen DS, Meuller LM: Activation of inositol phos-pholipid breakdown in HL60 cells by P2-purinergic receptors for extracellular ATP. Evidence for mediation by both pertussis toxin-sensitive and pertussis toxin-insensitive mechanisms. J Biol Chem, 1988; 263: 18108-18117
25. Dubyak GR, el-Moatassim C: Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol, 1993; 265: C577-C606
26. Putney JW: Excitement about calcium signaling in inexcitable cells. Science, 1993; 262: 676-678
27. Putney JW: Type 3 inositol 1, 4, 5-trisphosphate receptor and capacitative calcium entry. Cell Calcium, 1997; 21: 257-261
28. Jones KT, Sharpe GR: Thapsigargin raises intracellular free calcium levels in human keratinocytes and inhibits the coordinated expression of differentiation markers. Exp Cell Res, 1994; 210: 71-76
29. Harmon CS, Ducote J, Xiong V: Thapsigargin induces rapid, transient growth inhibition and c-fos expression followed by sustained growth stimulation in mouse keratinocyte cultures. J Invest Dermatol, 1996; 107: 188-194
30. 2+ entry by inositol phosphates-a possible mechanism. FEBS Lett, 1990; 263: 5-9
31. 2+-permeable channel. Nature, 1992; 355: 356-358
32. 2+ stores. FASEB J, 1992; 6: 786-792
33. + current by means of a phosphatase and a diffusible messenger. Nature, 1993; 364: 814-818
34. 2+ influx. Nature, 1993; 364: 809-814
35. 2+ entry by tyrosine kinase inhibitors. J Biol Chem, 1993; 268: 9945-9948
36. Striggow F, Bohnensack R: Inositol 1, 4, 5-trisphosphate activates receptor-mediated calcium entry by two different pathways in hepatocytes. Eur J Biochem, 1994; 222: 229-234
37. Petersen CC, Berridge MJ: Capacitative calcium entry is co-localized with calcium release in Xenopus oocytes: evidence against a highly diffusible calcium influx factor. Pflugers Arch. 1996; 432: 286-292
38. 2+ inflow in Xenopus laevis oocytes: inhibition by primaquine and evaluation of the role of membrane fusion. Biochem J, 1996; 319: 755-760
39. Holda JR, Blatter LA: Capacitative calcium entry is inhibited in vascular endothelial cells by disruption of cytoskeletal microfilaments. FEBS Lett, 1997; 403: 191-196
40. i signaling, but not for capacitative calcium entry. J Biol Chem, 1997; 272: 26555-26561
41. Ribeiro CM, Putney JW: Differential effects of protein kinase activation on calcium storage and capacitative calcium entry in N1H 3T3 cells. J Biol Chem, 1996; 271: 21522-21528
42. Rossier MF, Bird GS, Putney JW: Subcellular distribution of the calcium-storing inositol 1, 4, 5-trisphosphate-sensitive organelle in rat liver. Possible linkage to the plasma membrane through the actin microfilaments. Biochem J, 1991; 274: 643-650
43. Wang Y, Mattson MP, Furukawa K: Endoplasmic reticulum calcium release is modulated by actin polymerization. J Neurochemistry, 2002; 82: 945-952
44. Rafferty NS, Rafferty KA, Ito E: Agonist-induced rise in intracellular calcium of lens epithelial cells: effects on the actin cytoskeleton. Exp Eye Res, 1994; 59: 191-201
45. 2+ entry in vascular endothelial cells is mediated via pathways sensitive to 2 aminoethoxydiphenyl borate and xestospongin C. Br J Pharmacol, 2002; 135: 119-128
46. 2+ channels in rat hepatocytes. Biochem J, 2002; 363: 117-126
47. Karvonen SL, Korkiamäki T, Ylä-Outinen H et al: Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. J Invest Dermatol, 2000; 114: 693-700
48. Korkiamäki T, Ylä-Outinen H, Koivunen J et al: Mutations of NF1 Tumor Suppressor Gene Can Lead to Altered Calcium-mediated Cell Signalling. Am J Pathol, 2002; 160: 1981-1990
49. Gutmann DH, Wood DL, Collins FS: Identitication of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci, 1991; 88: 9658-9662
50. Gutmann DH, Aylsworth A, Carey JC et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA, 1997; 278: 51-57
51. Marchuk DA, Saulino AM, Tavakkol R et al: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics, 1991; 11: 931-940
52. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med, 1981; 305: 1617-1627
53. Xu GF, Lin B, Tanaka K et al: The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell, 1990; 63: 835-841
54. Basu TN, Gutmann DH, Fletcher JA et al: Aherrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature, 1992; 356: 713-715
55. Bollag G, McCormick F: Ras regulation. NF is enough of GAP. Nature, 1992; 356: 663-664
56. DeClue JE, Papageorge AG, Fletcher JA et al: Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell, 1992; 69: 265-273
57. Koivuen J, Ylä-Outinen H, Korkiamäki T et al: New funcfion for NF1 tumor suppressor. J Invest Dermatol, 2000; 114: 473-479
58. Bollag G, McCormick F, Clark R: Characterization of full-length neurofibromin: tubulin inhibits Ras GAP activity. EMBO J, 1993; 12: 1923-1927
59. Gregory PE, Gutmann DH, Mitchell A et al: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet, 1993; 19: 265-274
60. Xu H, Gutmann DH: Mutations in the GAP-related domain impair ability of neurofibromin in associate with microtubules. Brain Res, 1997; 759: 149-152
61. Gutmann DH, Wu YL, Hedrick NM et al: Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet, 2001; 10: 3009-3016
62. Li C, Cheng Y, Gutmann DA, Mangoura D: Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Brain Res Dev Brain Res, 2001; 130: 231-248
63. Peltonen J, Näntö-Salonen K, Aho HJ et al: Neurofibromatosis tumor and skin cells in culture. II. Structural proteins with special reference to the cytoskeletal and cell surface components. Acta Neuropathol, 1984; 63: 269-275
64. Boyce ST, Ham RG: Cultivation, frozen storage, and clonal growth of normal human keratinocytes in serum free media. J Tissue Cult Methods, 1985; 9: 83-93
65. Hughes AR, Takemura H, Putney JW: Kinetics of inositol 1,4, 5-trisphosphate and inositol cyclic 1: 2, 4, 5-trisphosphate metabolism in intact rat parotid acinar cells. Relationship to calcium signalling. J Biol Chem, 1988; 263: 10314-10319
66. Crespo P, Schuebel KE, Ostrom et al: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature, 1997; 385: 169-172
67. Hartwig JH, Bokoch GM, Carpenter CL et al: Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell, 1995; 82: 643-653
68. Ridley AJ, Paterson HF, Johnston CL et al: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell, 1992; 70: 401-410
69. 2+ channels. Science, 2000; 287: 1647-1651